118例脂肪肝患者血生化指标改变的分析  

Serum Biochemicals Analysis of Fatty Liver Disease

作　　者：郭刚[1] 姚华[1] 徐菲莉[2] 李华[2] 姚文海[2] 朱江丽[2] 沙蕾[2] 

机构地区：[1]新疆医科大学公共卫生学院,新疆乌鲁木齐830054 [2]新疆医科大学附属中医医院,新疆乌鲁木齐830000

出　　处：《地方病通报》2004年第3期17-20,共4页Endemic Diseases Bulletin

基　　金：乌鲁木齐市科学技术项目基金资助 (Y31 1 0 2 )

摘　　要：目的　探讨脂肪肝与血脂、血糖、酶的关系 ,为防治工作提供依据。方法　对体检B超检出的 118例脂肪肝患者及94名健康者 ,进行血清甘油三酯、胆固醇、载脂蛋白、血糖等分析。结果　脂肪肝组与非脂肪肝组相比GLU ,TG ,TC ,ApoA1,ApoB ,AST ,ALT明显升高 ,其余则无明显变化 ;脂肪肝组中主要以BMI >2 5患者为主 ;与脂代谢紊乱相关疾病的发生率在脂肪肝组显著上升。结论　脂肪肝与高血糖、高血脂、肝功能异常及BMI增高有关。Objective To investigate the relationship of fatty liver disease with plasma lipids, plasma glucose and serum enzymes etc., and supply evidences for prevention and treatment. MethodFasting serum biochemicals were measured and analyzed among 118 cases with fatty liver and 94 controls without fatty liver who were diagnosed by ultrasonic type B scanning. ResultLevel of GLU, TG, TC, ApoA1, ApoB, AST, ALT of fatty liver group were higher than those of the control group. People whose BMI>25 hold majority in the fatty liver group. The proportion of the diseases associated with lipid metabolism disorders increases in the fatty liver group. ConclusionFatty liver is closely associated with plasma lipids, plasma glucose and serum enzymes.

关 键 词：脂肪肝 血生化指标 

分 类 号：R575.5[医药卫生—消化系统] R446.11[医药卫生—内科学]